Skip to main content

Petter Bjornstad

NIH Rank #1539
  • Program Leader
  • R01 Holder
  • Top 10% Funded
  • Multi-Institutional
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 14629024Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine
  • Public Health
  • Pediatrics

NIH Funding · FY2024

Linked Award Amount
$4.1M
Full award amounts, FY2024
Award Records
6
Records listing this PI
Award-Linked Rank
#1,539
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Petter Bjornstad. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Petter Bjornstad as a PI. Multi-PI records show the full award amount for context.

  • 1U01DK142249-01U01
    Immunometabolism and the Cardio-Renal Axis in T1D-associated Atherosclerosis: Insights from the CaRe T1D Biobank
    $1.1M
    award amount
  • 1R01DK138915-01A1R01
    Advancing ADPKD Treatment with GLP-1RA: A Study of Glucagon-Like Peptide-1 Receptor Agonists' Efficacy, Safety, and Mechanism
    $692.9K
    award amount
  • 1R01DK137844-01R01
    Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients
    $665.8K
    award amount
  • 5R01HL165433-03R01
    Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)
    $610.7K
    award amount
  • 5R01DK132399-03R01
    Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohort
    $558.2K
    award amount
  • 7R01DK129211-04R01
    Puberty, diabetes, and the kidneys, when eustress becomes distress
    $515.7K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Petter Bjornstad as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Colorado
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1539
  6. 2024
    Entered Top 25% Nationally
    Ranked #1539
  7. 2024
    Entered Top 10% Nationally
    Ranked #1539
  8. 2025
    $5M Cumulative Funding
  9. 2025
    Multi-Institutional Research
    Awards at 3 institutions
  10. 2025
    R01 Grant Holder
  11. 2025
    Program/Center Grant Leader
  12. 2026
    $10M Cumulative Funding
  13. 2026
    Entered Top 5% Nationally
    Ranked #674